Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Mentens

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Microbiology|September 24, 2004
An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniaeW Scott Champney, Nicole Mentens, Kimberly Zurawick
Hemasphere|September 3, 2021
Oncogenic Cooperation Between IL7R-JAK-STAT Pathway MutationsInge Lodewijckx, Nicole Mentens, Kris Jacobs, et al.
Haematologica|January 4, 2011
MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell contextMaria Kleppe, Nicole Mentens, Thomas Tousseyn, et al.
Hemasphere|November 15, 2019
EML1-ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant ModelMarlies Vanden Bempt, Nicole Mentens, Peter Vandenberghe, et al.
Haematologica|March 31, 2022
TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemiaNaomi Thielemans, Sofie Demeyer, Nicole Mentens, et al.
Haematologica|January 19, 2007
The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitorsEls Lierman, Idoya Lahortiga, Helen Van Miegroet, et al.
Blood|February 28, 2002
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)Jan Cools, Nicole Mentens, Maria D Odero, et al.
Cancer Research|September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemiaJan Cools, Nicole Mentens, Pascal Furet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylateHans Prenen, Jan Cools, Nicole Mentens, et al.
Genes, Chromosomes & Cancer|July 12, 2002
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumorJan Cools, Iwona Wlodarska, Riet Somers, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Microbiology|September 24, 2004
An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniaeW Scott Champney, Nicole Mentens, Kimberly Zurawick
Hemasphere|September 3, 2021
Oncogenic Cooperation Between IL7R-JAK-STAT Pathway MutationsInge Lodewijckx, Nicole Mentens, Kris Jacobs, et al.
Haematologica|January 4, 2011
MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell contextMaria Kleppe, Nicole Mentens, Thomas Tousseyn, et al.
Hemasphere|November 15, 2019
EML1-ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant ModelMarlies Vanden Bempt, Nicole Mentens, Peter Vandenberghe, et al.
Haematologica|March 31, 2022
TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemiaNaomi Thielemans, Sofie Demeyer, Nicole Mentens, et al.
Haematologica|January 19, 2007
The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitorsEls Lierman, Idoya Lahortiga, Helen Van Miegroet, et al.
Blood|February 28, 2002
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)Jan Cools, Nicole Mentens, Maria D Odero, et al.
Cancer Research|September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemiaJan Cools, Nicole Mentens, Pascal Furet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylateHans Prenen, Jan Cools, Nicole Mentens, et al.
Genes, Chromosomes & Cancer|July 12, 2002
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumorJan Cools, Iwona Wlodarska, Riet Somers, et al.
Pageof 4